Silica-lipid hybrid microcapsules: Influence of lipid and emulsifier type on in vitro performance

International Journal of Pharmaceutics

Volumn 409, Issue 1-2, 2011, Pages 297-306

  Lim, Li Hui ^a   Tan, Angel ^a   Simovic, Spomenka ^a   Prestidge, Clive A ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

In vitro dissolution; In vitro lipid digestion; Lipid based formulations; Oral delivery; Poorly water soluble drug

Indexed keywords

COUMARIN; DIACYLGLYCEROL; DRUG CARRIER; EMULSIFYING AGENT; LIPID EMULSION; LONG CHAIN TRIACYLGLYCEROL; MEDIUM CHAIN MONODIGLYCERIDE; MEDIUM CHAIN TRIACYLGLYCEROL; OLEYLAMINE; PHOSPHATIDYLCHOLINE; SILICON DIOXIDE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL COMPOSITION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; DRUG SOLUTION; DRUG STRUCTURE; EMULSION; IN VITRO STUDY; LIPOLYSIS; LIPOPHILICITY; MICELLE; MICROCAPSULE; PHASE PARTITIONING; PRIORITY JOURNAL; SOLUBILIZATION;

AMINES; CAPSULES; COUMARINS; DIGLYCERIDES; DRUG DELIVERY SYSTEMS; EMULSIONS; EXCIPIENTS; INTESTINES; LECITHINS; LIPOLYSIS; POROSITY; SILICON DIOXIDE; SOLUBILITY; TRIGLYCERIDES;

EID: 79955044994     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.02.038     Document Type: Article

References (36)

1. M. Baker Dissolution Media Concentrates 2007 OCon Chemicals Ltd.
2. S. Chakraborty, D. Shukla, B. Mishra, and S. Singh Lipid - an emerging platform for oral delivery of drugs with poor bioavailability Eur. J. Pharm. Biopharm. 73 2009 1 15
3. K.L. Christensen, G.P. Pedersen, and H.G. Kristensen Preparation of redispersible dry emulsions by spray drying Int. J. Pharm. 212 2001 187 194 (Pubitemid 32119444)
4. A. Dahan, and A. Hoffman Rationalising the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs J. Control. Release 129 2008 1 10
5. S. Duinhoven, R. Poort, G. Van der Voet, W.G.M. Agterof, W. Norde, and J. Lyklema Driving forces for enzyme adsorption at solid-liquid interfaces: 2. The fungal lipase lipolase J. Colloid Interface Sci. 170 1995 351 357
6. D.G. Fatouros, D.M. Karpf, F.S. Nielsen, and A. Mullertz Clinical studies with oral lipid based formulations of poorly soluble compounds Ther. Clin. Risk Manage. 3 2007 591 604 (Pubitemid 47496964)
7. D.G. Fatouros, F.S. Nielsen, D. Douroumis, L.J. Hadjileontiadis, and A. Mullertz In vitro-in vivo correlations of self-emulsifying drug delivery systems combining the dynamic lipolysis model and neuro-fuzzy networks Eur. J. Pharm. Biopharm. 69 2008 887 898
8. N. Ghouchi Eskandar, and S. Simovic Synergistic effect of silica nanoparticles and charged surfactants in the formation and stability of submicron oil-in-water emulsions Phys. Chem. Chem. Phys. 9 2007 6426 6434
9. D.J. Hauss Oral lipid-based formulations Adv. Drug Deliv. Rev. 59 2007 667 676 (Pubitemid 47285409)
10. K. Heinzelmann, and K. Franke Using freezing and drying techniques of emulsions for the microencapsulation of fish oil to improve oxidation stability Colloid Surf. B 12 1999 223 229 (Pubitemid 29073756)
11. A.J. Humberstone, and W.N. Charman Lipid-based vehicles for the oral delivery of poorly water soluble drugs Adv. Drug Deliv. Rev. 25 1997 103 128
12. D.-J. Jang, E.J. Jeong, H.-M. Lee, B.-C. Kim, S.-J. Lim, and C.-K. Kim Improvement of bioavailability and photostability of amlodipine using redispersible dry emulsion Eur. J. Pharm. Sci. 28 2006 405 411 (Pubitemid 44038349)
13. C. Leuner, and J. Dressman Improving drug solubility for oral delivery using solid dispersions Eur. J. Pharm. Biopharm. 50 2000 47 56
14. K.J. MacGregor, J.K. Embleton, J.E. Lacy, E.A. Perry, L.J. Solomon, H. Seager, and C.W. Pouton Influence of lipolysis on drug absorption from the gastro-intestinal tract Adv. Drug Deliv. Rev. 25 1997 33 46 (Pubitemid 27107789)
15. A. Mirfazaelian, and M. Mahmoudian A simple pharmacokinetics subroutine for modeling double peak phenomenon Biopharm. Drug Dispos. 27 2006 119 124
16. V.J. Mohanraj, T.J. Barnes, and C.A. Prestidge Silica nanoparticle coated liposomes: a new type of hybrid nanocapsule for proteins Int. J. Pharm. 392 2010 285 293
17. C. Molina, and R. Cadorniga Physical stability of lyophilized and sterilized emulsions S.T.P. Pharma Pratiques 5 1995 63 72
18. S.L. Myers, and M.L. Shively Preparation and characterisation of emulsifiable glasses: oil-in-water and water-in-oil-in-water emulsions J. Colloid Interface Sci. 149 1992 271 278
19. F.S. Nielsen, E. Gibault, H. Ljusberg-Wahren, L. Arleth, J.S. Pedersen, and A. Müllertz Characterization of prototype self-nanoemulsifying formulations of lipophilic compounds J. Pharm. Sci. 96 2007 876 892 (Pubitemid 46657875)
20. G.P. Pedersen, P. Fäldt, B. Bergensthl, and H.G. Kristensen Solid state characterisation of a dry emulsion: a potential drug delivery system Int. J. Pharm. 171 1998 257 270 (Pubitemid 29023117)
21. G.H. Peters, U. Dahmen-Levison, K. De Meijere, G. Brezesinski, S. Toxvaerd, H. Möhwald, A. Svendsen, and P.K.J. Kinnunen Influence of surface properties of mixed monolayers on lipolytic hydrolysis Langmuir 16 2000 2779 2788 (Pubitemid 30576805)
22. G. Pieroni, and R. Verger Hydrolysis of mixed monomolecular films of triglyceride/lecithin by pancreatic lipase J. Biol. Chem. 254 1979 10090 10094
23. C.J.H. Porter, A.M. Kaukonen, A. Taillardat-Bertschinger, B.J. Boyd, J.M. O'Connor, G.A. Edwards, and W.N. Charman Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with Halofantrine J. Pharm. Sci. 93 2004 1110 1121 (Pubitemid 38529685)
24. C.J.H. Porter, C.W. Pouton, J.F. Cuine, and W.N. Charman Enhancing intestinal drug solubilisation using lipid-based delivery systems Adv. Drug Deliv. Rev. 60 2008 673 691
25. C.J.H. Porter, N.L. Trevaskis, and W.N. Charman Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs Nat. Rev. Drug Disc. 6 2007 231 248 (Pubitemid 46344627)
26. L. Sek, C.J.H. Porter, A.M. Kaukonen, and W.N. Charman Evaluation of the in-vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products J. Pharm. Pharmacol. 54 2002 29 41 (Pubitemid 34116220)
27. S. Simovic, P. Heard, H. Hui, Y. Song, F. Peddie, A.K. Davey, A. Lewis, T. Rades, and C.A. Prestidge Dry hybrid lipid-silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs Mol. Pharm. 6 2009 861 872
28. S. Simovic, H. Hui, Y. Song, A.K. Davey, T. Rades, and C.A. Prestidge An oral delivery system for indomethicin engineered from cationic lipid emulsions and silica nanoparticles J. Control. Release 143 2010 367 373
29. T. Takagi, C. Ramachandran, M. Bermejo, S. Yamashita, L.X. Yu, and G.L. Amidon A provisional biopharmaceutical classification of the top 200 drug products in the United States, Great Britain, Spain, and Japan Mol. Pharm. 3 2006 631 643 (Pubitemid 46087480)
30. H. Takeuchi, H. Sasaki, T. Niwa, T. Hino, Y. Kawashima, K. Uesugi, and H. Ozawa Design of redispersible dry emulsion as an advanced dosage form of oily drug (vitamin E nicotinate) by spray-drying technique Drug Dev. Ind. Pharm. 18 1992 919 937
31. H. Takeuchi, H. Sasaki, T. Niwa, T. Hino, Y. Kawashima, K. Uesugi, and H. Ozawa Improvement of photostability of ubidecarenone in the formulation of a novel powdered dosage form termed redispersible dry emulsion Int. J. Pharm. 86 1992 25 33
32. A. Tan, S. Simovic, A.K. Davey, T. Rades, B.J. Boyd, and C.A. Prestidge Silica nanoparticles to control the lipase-mediated digestion of lipid-based oral delivery systems Mol. Pharm. 7 2010 522 532
33. A. Tan, S. Simovic, A.K. Davey, T. Rades, and C.A. Prestidge Silica-lipid hybrid (SLH) microcapsules: a novel oral delivery system for poorly soluble drugs J. Control. Release 134 2009 62 70
34. N.L. Trevaskis, W.N. Charman, and C.J.H. Porter Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update Adv. Drug Deliv. Rev. 60 2008 702 716
35. U.S. Food and Drug Administration Guidance for Industry: Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System 2000 Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research Rockville, MD, U.S.
36. N.H. Zangenberg, A. Müllertz, H.G. Kristensen, and L. Hovgaard A dynamic in vitro lipolysis model. I. Controlling the rate of lipolysis by continuous addition of calcium Eur. J. Pharm. Sci. 14 2001 115 122 (Pubitemid 32737533)